208 related articles for article (PubMed ID: 18235848)
1. Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade.
Simeonov A; Jadhav A; Sayed AA; Wang Y; Nelson ME; Thomas CJ; Inglese J; Williams DL; Austin CP
PLoS Negl Trop Dis; 2008 Jan; 2(1):e127. PubMed ID: 18235848
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.
Lyu H; Petukhov PA; Banta PR; Jadhav A; Lea WA; Cheng Q; Arnér ESJ; Simeonov A; Thatcher GRJ; Angelucci F; Williams DL
ACS Infect Dis; 2020 Mar; 6(3):393-405. PubMed ID: 31939288
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.
Kuntz AN; Davioud-Charvet E; Sayed AA; Califf LL; Dessolin J; Arnér ES; Williams DL
PLoS Med; 2007 Jun; 4(6):e206. PubMed ID: 17579510
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis.
Li T; Ziniel PD; He PQ; Kommer VP; Crowther GJ; He M; Liu Q; Van Voorhis WC; Williams DL; Wang MW
Infect Dis Poverty; 2015 Aug; 4():40. PubMed ID: 26341081
[TBL] [Abstract][Full Text] [Related]
5. Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH Entry.
Silvestri I; Lyu H; Fata F; Boumis G; Miele AE; Ardini M; Ippoliti R; Bellelli A; Jadhav A; Lea WA; Simeonov A; Cheng Q; Arnér ESJ; Thatcher GRJ; Petukhov PA; Williams DL; Angelucci F
ACS Chem Biol; 2018 Aug; 13(8):2190-2202. PubMed ID: 29800515
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum.
Song L; Li J; Xie S; Qian C; Wang J; Zhang W; Yin X; Hua Z; Yu C
PLoS One; 2012; 7(2):e31456. PubMed ID: 22384025
[TBL] [Abstract][Full Text] [Related]
7. A 1,536-well-based kinetic HTS assay for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.
Lea WA; Jadhav A; Rai G; Sayed AA; Cass CL; Inglese J; Williams DL; Austin CP; Simeonov A
Assay Drug Dev Technol; 2008 Aug; 6(4):551-5. PubMed ID: 18665782
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.
Huang J; Hua W; Li J; Hua Z
Mol Med Rep; 2015 Oct; 12(4):5787-95. PubMed ID: 26239395
[TBL] [Abstract][Full Text] [Related]
9. Identification of oxadiazoles as new drug leads for the control of schistosomiasis.
Sayed AA; Simeonov A; Thomas CJ; Inglese J; Austin CP; Williams DL
Nat Med; 2008 Apr; 14(4):407-12. PubMed ID: 18345010
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs.
Johann L; Belorgey D; Huang HH; Day L; Chessé M; Becker K; Williams DL; Davioud-Charvet E
FEBS J; 2015 Aug; 282(16):3199-217. PubMed ID: 26111549
[TBL] [Abstract][Full Text] [Related]
11. New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni.
Guglielmo S; Cortese D; Vottero F; Rolando B; Kommer VP; Williams DL; Fruttero R; Gasco A
Eur J Med Chem; 2014 Sep; 84():135-45. PubMed ID: 25016371
[TBL] [Abstract][Full Text] [Related]
12. The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase.
Alger HM; Williams DL
Mol Biochem Parasitol; 2002 Apr; 121(1):129-39. PubMed ID: 11985869
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular bases of antischistosomal therapy.
Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
[TBL] [Abstract][Full Text] [Related]
14. Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography.
Angelucci F; Dimastrogiovanni D; Boumis G; Brunori M; Miele AE; Saccoccia F; Bellelli A
J Biol Chem; 2010 Oct; 285(42):32557-67. PubMed ID: 20659890
[TBL] [Abstract][Full Text] [Related]
15. Comparative modeling of thioredoxin glutathione reductase from Schistosoma mansoni: a multifunctional target for antischistosomal therapy.
Sharma M; Khanna S; Bulusu G; Mitra A
J Mol Graph Model; 2009 Feb; 27(6):665-75. PubMed ID: 19070522
[TBL] [Abstract][Full Text] [Related]
16. Cheminformatics models for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.
Gaba S; Jamal S; Open Source Drug Discovery Consortium ; Scaria V
ScientificWorldJournal; 2014; 2014():957107. PubMed ID: 25629082
[TBL] [Abstract][Full Text] [Related]
17. QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni.
Melo-Filho CC; Dantas RF; Braga RC; Neves BJ; Senger MR; Valente WC; Rezende-Neto JM; Chaves WT; Muratov EN; Paveley RA; Furnham N; Kamentsky L; Carpenter AE; Silva-Junior FP; Andrade CH
J Chem Inf Model; 2016 Jul; 56(7):1357-72. PubMed ID: 27253773
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects.
Angelucci F; Sayed AA; Williams DL; Boumis G; Brunori M; Dimastrogiovanni D; Miele AE; Pauly F; Bellelli A
J Biol Chem; 2009 Oct; 284(42):28977-85. PubMed ID: 19710012
[TBL] [Abstract][Full Text] [Related]
19.
Oyinloye BE; Shamaki DE; Agbebi EA; Onikanni SA; Ubah CS; Aruleba RT; Dao TNP; Owolabi OV; Idowu OT; Mathenjwa-Goqo MS; Esan DT; Ajiboye BO; Omotuyi OI
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731401
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of oxadiazole-2-oxide derivatives as potential drug candidates for schistosomiasis targeting SjTGR.
Li G; Guo Q; Feng C; Chen H; Zhao W; Li S; Hong Y; Sun D
Parasit Vectors; 2021 Apr; 14(1):225. PubMed ID: 33902686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
